CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

JPMorgan Initiates Coverage on Rhythm Pharmaceuticals With Overweight Rating, $145 Price Target

Positive
AI Analysis

Summary

JPMorgan initiates coverage on Rhythm Pharmaceuticals with an Overweight rating and $145 price target.

Importance:2/10
Sentiment:
0.60
analyst_coverageequity_researchprice_target
Related Companies

Read the original article

Published by yahoo_finance on July 27, 2026 11:55 AM

Read Original